| Literature DB >> 34631244 |
Mica R Harr1, Cody J Mansfield2, Bailey Urbach1, Matt Briggs3, James Onate4, Laura C Boucher4.
Abstract
BACKGROUND: Shooting sports are included in collegiate and Olympic events. However, there is minimal evidence examining injury prevalence and incidence for these athletes. HYPOTHESIS/Entities:
Keywords: athletic injuries; biathlon; low back pain; shooting sports
Year: 2021 PMID: 34631244 PMCID: PMC8486400 DOI: 10.26603/001c.28231
Source DB: PubMed Journal: Int J Sports Phys Ther ISSN: 2159-2896

Figure 1. Postures of Athletes in Rifle, Shotgun, and Pistol Events

Figure 2. Example of Biathlon Athletes

Figure 3. PRISMA Diagram
Table 1. PICO Question
| P | Any individual participating in an Olympic-style shooting event, including, but not limited to summer and winter Olympics, and NCAA competition. |
| I | Not applicable, assessing for injury rate, incidence, definition of injury used by researchers and prevalence. |
| C | Compare data between different shooting athletic events (Olympic vs NCAA vs other) and sex differences (male vs female) |
| O | Data of interest: injury rate, incidence, prevalence, and how injury was defined by researchers |
Table 2. NIH Quality Assessment Tool for Internal Validity of Cohort and Cross-Sectional Studies
| Author and Year | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | Q14 | Total | Quality Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kabak et al., 2015 | Y | Y | NR | Y | N | N | N | Y | N | N | N | N | NA | N | 4 | Poor |
| Muller et al., 2017 | Y | Y | NR | Y | N | N | N | Y | Y | N | N | N | NA | Y | 6 | Fair |
| Zeman and Pitr, 2001 | Y | Y | NR | Y | N | N | N | Y | Y | N | Y | N | NA | N | 6 | Fair |
| Blut et al., 2010 | Y | Y | N | Y | N | N | N | Y | N | N | N | N | NA | Y | 5 | Poor |
| Derman et al., 2016 | Y | Y | Y | Y | N | N | N | Y | N | Y | Y | Y | NR | Y | 9 | Good |
| Wilber et al., 2000 | Y | Y | NR | Y | N | N | N | NA | Y | N | Y | N | NA | N | 5 | Poor |
| Kujala et al., 1995 | Y | Y | Y | Y | N | Y | Y | N | Y | N | Y | Y | NA | Y | 10 | Good |
| Noormohammadpour et al., 2016 | Y | Y | Y | Y | N | N | N | Y | N | N | N | N | NA | Y | 6 | Fair |
| Volski et al., 1986 | Y | Y | N | Y | N | N | N | N | Y | N | Y | N | NA | N | 5 | Poor |
| Osteras et al., 2013 | Y | Y | Y | Y | N | N | N | Y | Y | N | Y | N | NA | Y | 8 | Fair |
| Junge et al., 2009 | Y | Y | Y | Y | N | N | N | Y | Y | N | N | Y | NA | N | 7 | Fair |
| Engebretsen et al., 2010 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Engebretsen et al., 2013 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Palmer-Green and Elliot, 2015 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Soligard et al., 2016 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Soligard et al., 2017 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Soligard et al., 2019 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Laoruengthana et al., 2009 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
| Engebretsen et al., 2015 | Y | Y | Y | Y | N | N | N | Y | Y | Y | Y | Y | N | N | 9 | Good |
Y = Yes. N = No. NR = Not Reported. NA = Not Applicable. Poor = high risk of bias (1-5 Y). Fair = moderate risk of bias (6-8 Y). Good = low risk of bias (9-14 Y).
Q1. Was the research question or objective in this paper clearly stated?, Q2. Was the study population clearly specified and defined?, Q3. Was the participation rate of eligible persons at least 50%?, Q4. Were all the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants?, Q5. Was a sample size justification, power description, or variance and effect estimates provided?, Q6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured?, Q7. Was the timeframe sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed?, Q8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure, or exposure measured as continuous variable)?, Q9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently across all study participants?, Q10. Was the exposure(s) assessed more than once over time?, Q11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants?, Q12. Were the outcome assessors blinded to the exposure status of participants?, Q13. Was loss to follow-up after baseline 20% or less?, Q14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)?
Table 3. Johanna Briggs Institute Critical Appraisal Tool for Risk of Bias of Analytical Cross-Sectional Studies
| Author and Year | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Total | Quality Rating |
|---|---|---|---|---|---|---|---|---|---|---|
| Kabak et al., 2015 | Y | Y | U | Y | Y | Y | U | Y | 6 | Good |
| Muller et al., 2017 | Y | Y | Y | U | Y | N | Y | Y | 6 | Good |
| Zeman and Pitr, 2001 | U | N | U | U | Y | N | U | U | 1 | Poor |
| Blut et al., 2010 | Y | Y | Y | U | Y | Y | U | Y | 6 | Good |
| Kujala et al., 1995 | Y | Y | U | Y | Y | Y | U | Y | 6 | Good |
| Noormohammadpour et al., 2016 | Y | Y | Y | Y | Y | Y | U | Y | 7 | Good |
| Volski et al., 1986 | U | U | U | U | Y | U | Y | Y | 3 | Poor |
| Osteras et al., 2013 | Y | Y | Y | Y | Y | U | Y | Y | 7 | Good |
Y = Yes. N = No. U = Unclear. Poor = high risk of bias (1-3 Y). Fair = moderate risk of bias (4-5 Y). Good = low risk of bias (6-8 Y).
Q1. Were the criteria for inclusion in the sample clearly defined?, Q2. Were the study subjects and the setting described in detail?, Q3. Was the exposure measured in a valid and reliable way?, Q4. Were objective, standard criteria used for measurement of the condition?, Q5. Were confounding factors identified?, Q6. Were strategies to deal with confounding factors stated?, Q7. Were the outcomes measured in a valid and reliable way?, Q8. Was appropriate statistical analysis used?
Table 4. Johanna Briggs Institute Critical Appraisal Tool for Risk of Bias of Cohort Studies
| Author and Year | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Total | Quality Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Derman et al., 2016 | Y | Y | Y | Y | Y | U | Y | Y | Y | NA | Y | 9 | Good |
| Wilber et al., 2000 | Y | Y | Y | Y | N | Y | Y | Y | Y | NA | N | 8 | Good |
| Junge et al., 2009 | Y | Y | Y | Y | N | Y | Y | Y | Y | NA | Y | 9 | Good |
| Engebretsen et al., 2010 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
| Engebretsen et al., 2013 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
| Palmer-Green and Elliot, 2015 | Y | Y | Y | U | N | Y | Y | Y | Y | NA | Y | 8 | Good |
| Soligard et al., 2016 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
| Soligard et al., 2017 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
| Soligard et al., 2019 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
| Laoruengthana et al., 2009 | Y | Y | U | Y | U | Y | U | Y | Y | NA | Y | 7 | Fair |
| Engebretsen et al., 2015 | Y | Y | Y | Y | Y | Y | Y | Y | Y | NA | Y | 10 | Good |
Y = Yes. N = No. U = Unclear. NA = Not Applicable. Poor = high risk of bias (1-4 Y). Fair = moderate risk of bias (5-7 Y). Good = low risk of bias (8-11 Y).
Q1. Were the two groups similar and recruited from the same population?, Q2. Were the exposures measured similarly to assign people to both exposed and unexposed groups?, Q3. Was the exposure measured in a valid and reliable way?, Q4. Were confounding factors identified?, Q5. Were strategies to deal with confounding factors stated?, Q6. Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?, Q7.Were the outcomes measured in a valid and reliable way?, Q8. Was the follow up time reported and sufficient to be long enough for outcomes to occur?, Q9. Was follow up complete, and if not, were the reasons to loss to follow up described and explored?, Q10. Were strategies to address incomplete follow up utilized?, Q11.Was appropriate statistical analysis used?
Table 5. Incidence and Prevalence Data
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Kabak et al., 2015 | 2010-2011 Turkish Shooting Sports Championship | n=729 shooting athletes | n=729 shooting | 93 | 93/729 | 12.80% | 444 (60.9%) male, 285 (39.15) female | 62 (14.0%) male, 31 (10.9%) female |
| Muller et al., 2017 | 2015 Brandenburg, Germany sport schools | n=2116 adolescent athletes | n=59 shooting | n/a | n/a | greater than or = 10% | n/a | n/a |
| Zeman and Pitr, 2001 | 1998 Czech Internationals | n=43 sports shooters | n=19 rifle, n=10 running target, n=14 pistol | n/a | n/a | n/a | 34 (79.1%) male, 9 (20.9%) female | n/a |
| Blut et al., 2010 | 2008-2009 Biathlon World Cup event | n=116 biathlon athletes | n=116 biathlon | 47 | 47/116 | 40.50% | (44%) male, (56%) female | (39.7%) male, (54.4%) female |
| Derman et al., 2016 | 2014 Winter Paralympics | n=547 athletes | n=149 biathlon/cross-country skiing | 15 | 15/149 | 10.00% | 95 (63.8%) male, 54 (36.2%) female | n/a |
| Wilber et al., 2000 | 1998 US Winter Olympic Team | n=170 athletes | n=34 biathlon | 0 | 0 | 0% | n/a | n/a |
| Kujala et al., 1995 | 1920-1965 Finland top athletes | n=117 athletes | n=29 shooting | n/a | n/a | 3% | 29 (100%) male | n/a |
| Noormohammadpour et al., 2016 | 2014 National Sports Olympiad of Female University Students | n=1059 athletes | n=91 shooting | n/a | n/a | 29.70% | 91 (100%) female | n/a |
| Volski et al., 1986 | 1983 International Shooting Championships | n=80 shooting athletes | n=52 rifle, n=25 pistol n=3 non-designated | n/a | n/a | 63% | 59 (74%) male, 21 (286%) female | n/a |
| Osteras et al., 2013 | 2007 Females with Norwegian Biathlon Federation license | n=148 biathlon athletes | n=148 biathlon | 85 | 85/148 | 57.40% | 148 (100%) female | n/a |
| Junge et al., 2009 | 2008 Summer Olympics | n=10977 Olympic athletes | n=386 shooting | 3 | 3/386 | 0.78% | n/a | n/a |
| Engebretsen et al., 2010 | 2010 Winter Olympics | n=2567 Olympic athletes | n=202 biathlon | 3 | 3/202 | 1.50% | 104 (51.5%) male, 98 (48.5%) female | 2 (1.9%) male, 1 (1.0%) female |
| Engebretsen et al., 2013 | 2012 Summer Olympics | n=10568 Olympic athletes | n=390 shooting | 15 | 15/390 | 3.80% | 231 (59.2%) male, 159 (40.8%) female | 4 (1.7%) male, 11 (6.9%) female |
| Palmer-Green and Elliot, 2015 | 2014 Winter Olympics GB Team | n=56 athletes | n=2 biathlon | 0 | 0 | 0% | n/a | n/a |
| Soligard et al., 2016 | 2014 Winter Olympics | n=2788 Olympic athletes | n=204 biathlon | 14 | 14/204 | 6.90% | 105 (51.5%) male, 99 (48.5%) female | 9 (8.6%) male, 5 (5.1%) female |
| Soligard et al., 2017 | 2016 Summer Olympics | n=11274 Olympic athletes | n/a | n/a | n/a | 0-3% | n/a | n/a |
| Soligard et al., 2019 | 2018 Winter Olympics | n=2914 Olympic athletes | n/a | n/a | n/a | 2% | n/a | n/a |
| Laoruengthana et al., 2009 | 2008 Tailand National "Phisanulok" Games | n=12199 athletes | n=771 shooting | 0 | 0 | 0% | 469 (60.8%) male, 302 (39.2%) female | n/a |
| Engebretsen et al., 2015 | 2008 & 2010 Olympics | * | * | * | * | * | * | * |
Combined data from Junge et al., 2009 and Engebretsen et al., 2010

Figure 4. Prevalence of Shooting Injuries by Olympic Year
| Specific Search | Term Combination |
|---|---|
| Gun | Rifle or Firearms or Shotguns or Pistols or Shooting or Shooting Sports or Pistols or Skeet or Air Rifle or Air Pistol or Rapid Fire Pistol or Rapid Fire or Biathlon |
| Event/organization | Olympics or Olympic or NCAA or National Collegiate Athletic Association or Club or Collegiate or World Cup or Sport or Competition or Match or Summer or Winter or USA Shooting or NRA or National Rifle Association or CMP or Civilian Marksmanship Program or ASSA or American Smallbore Shooting Association or Championships or Nationals or PyeongChang 2018 or Rio 2016 or Sochi or Sochi 2014 or London or London 2012 or Vancouver or Vancouver 2010 or Beijing or Beijing 2008 or Turin or Turin 2006 or Athens or Athens 2004 or Salt Lake or Salt Lake 2002 or Sydney or Sydney 2000 or Nagano or Nagano 1998 or Atlanta or Atlanta 1996 |
| Profession | Sports Medicine or Physical Therapy or Performance or Athletic Training or Physiotherapist or Injury Muscle Stretching or Muscle Stretching Musculoskeletal Manipulations or Musculoskeletal or Breathing Exercises or Manipulations or Orthopedic or Osteopathic or Spinal or Soft Tissue or Trauma or Incidence or Injury Surveillance or Athlete or Athletic Injuries or Epidemiology or Medical Records or Population Surveillance or Risk Factors or Prospective Studies or Comparative Study or Statistics or Numerical Data |
| “not” terms | War or Warfare or Suicide or Law or Police or Chemistry |